tiprankstipranks
Avalo Therapeutics (AVTX)
NASDAQ:AVTX
Holding AVTX?
Track your performance easily

Avalo Therapeutics (AVTX) Cash flow

889 Followers

Avalo Therapeutics Cash Flow

AVTX's free cash flow for Q3 2024 was $-11.50M. For the 2024 fiscal year, AVTX's free cash flow was decreased by $-3.97M and operating cash flow was $-11.50M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -36.77M$ -30.68M$ -26.75M$ -70.89M$ -40.54M$ -19.13M
Investing Cash Flow
$ 356.00K$ -133.00K$ -95.00K$ -113.00K$ 11.13M$ -443.00K
Financing Cash Flow
$ 108.14M$ 25.04M$ -14.70M$ 106.76M$ 44.78M$ 12.56M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 293.45M$ 7.55M$ 13.32M$ 54.86M$ 19.11M$ 3.73M
Income Tax Paid Supplemental Data
----$ 474.00K$ 1.80M
Interest Paid Supplemental Data
-$ 1.93M$ 2.93M$ 1.58M-$ 1.05M
Issuance Of Capital Stock
$ 115.63M$ 67.00K$ 73.00K$ 29.41M$ 39.63M$ 12.90M
Issuance Of Debt
-$ -21.24M$ -14.81M--$ -256.14K
Repayment Of Debt
-$ -21.24M$ -14.81M--$ -256.14K
Free Cash Flow
$ -36.77M$ -30.81M$ -26.85M$ -71.00M$ -40.60M$ -19.40M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Avalo Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis